Fluticasone furoate
Fluticasone furoate has been studied in 1 paper since 2025: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, May 12, 2025: “COPD in elderly patients”.
- 3 trials, none about aging
Who is developing Fluticasone furoate?
1 company: Novartis Pharmaceuticals.
- Companies
- Novartis PharmaceuticalsPhase 3asthma
Trial sponsors
Company1 trialPhase 41,358 people
Novartis Pharmaceuticals Corporation
Company1 trialPhase 3188 people
1 trialPhase 4182 people